-
Continue reading →: NVIDIA bearish momentum explained
The market is testing a new narrative for $NVDA. This will be a bull and bear ferocious fight, but the current bear thinking is the following: 1. Overcapacity Risk in Semiconductors: The AI Bubble Narrative Key Issue: Overinvestment Based on Overhyped Demand NVIDIA’s meteoric rise has been fueled by the…
-
Continue reading →: Hermès: A Fantastic BusinessHermès $HESAY is a very interesting brand. It relies solely on craftsmanship and savoir-faire to manufacture its goods. It all boils down to the materials and skills working around those materials, cutting and stitching are more than simple tasks. They are the difference between a bag that costs thousands of…
-
Continue reading →: Magic Touch or Misstep? Reflections on Tapestry $TPRI’ve talked about $TPR before, and I’m sticking to my guns here. They tried to pull off a Louis Vuitton $LVMUY, but let’s be real: it’s not hitting the mark. They brought Stuart Weitzman in 2015 and Kate Spade in 2018 into the fold, thinking they could sprinkle some of…
-
Continue reading →: Invitae’s High-Stakes Financial Maneuvering: Dilution Might Not Be That BadInvitae Corporation (NVTA) faces significant challenges in addressing its liquidity concerns. The firm is exploring multiple strategies to stabilize its financial and operational footing. These strategies encompass potential capital raising, asset divestitures, strategic refocusing on core business and R&D activities, curtailment of capital spending, operating cost reductions, and managing debt…
-
Continue reading →: A primer on the impact of gene therapies and CASGEVY on CRISPR AG and the industryCASGEVY approval CASGEVY is a groundbreaking gene therapy, owned by CRISPR AG (CRSP) and Vertex (VRTX) specifically designed for the treatment of sickle cell disease (SCD) in individuals aged 12 and older who experience frequent vaso-occlusive crises (VOCs). Developed through a collaboration between Vertex Pharmaceuticals and CRISPR Therapeutics, CASGEVY stands…
-
Continue reading →: China’s Economic Crossroads: Navigating the Delicate BalanceGiven China’s significant role as a key player in the global economy, I maintain a vigilant and analytical approach to Professor Michael Pettis’ insights on its economic strategies. Pettis has long maintained that China’s reliance on supply-side stimulus is a misstep. This is pivotal as China, being the world’s second-largest…
-
Continue reading →: Loose thoughts in a time of uncertaintyAs we navigate the currents of today’s financial markets, we’re witnessing a striking contrast between the resilience of equities and the cautious stance of the bond market. Equity markets, it seems, are choosing to overlook looming challenges, clinging to a narrative of a ‘soft landing’ for the economy. On the…
-
Continue reading →: Dissecting the Causes of Inflation
The macro landscape is painting a fascinating picture of the inflationary environment, especially when we dive deep into the underlying narratives. The NBER folks help us get a more precise picture of what caused inflation. They concluded the following: 1. First, let’s not underestimate the magnitude of the U.S.’s fiscal…
-
Continue reading →: Quick Takes: Grayscale’s Victory & The Evolution of Cryptocurrency RegulationExecutive Summary: Grayscale Investments’ recent court ruling in favor of launching the first-ever Bitcoin ETF in the U.S. is a watershed moment for the cryptocurrency ecosystem. Beyond the immediate market reaction, this event points towards a maturing regulatory environment and sets a potential precedent for the broader adoption of crypto-focused…
-
Continue reading →: A Macro Perspective on Wealth Transfers: From the French Revolution to BitcoinWealth transfers have, throughout history, acted as a cornerstone of societal evolution. These transfers are not mere shifts of assets from one hand to another; they represent changes in power dynamics, socio-economic structures, and often herald a new epoch in human civilization. The French Revolution: A Primer on Wealth Transfer…





